sotalol has been researched along with Ventricular Dysfunction in 3 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Couderc, JP | 1 |
Kaab, S | 1 |
Hinterseer, M | 1 |
McNitt, S | 1 |
Xia, X | 1 |
Fossa, A | 1 |
Beckmann, BM | 1 |
Polonsky, S | 1 |
Zareba, W | 1 |
Olesin, AI | 1 |
Shabrov, AV | 1 |
Sinenko, VI | 1 |
Popik, GS | 1 |
Boldueva, SA | 1 |
Leonova, IA | 1 |
Poloskina, OA | 1 |
Delacrétaz, E | 1 |
Fuhrer, J | 1 |
1 trial available for sotalol and Ventricular Dysfunction
Article | Year |
---|---|
Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Male; Middle Aged; Sotalol; Torsades de | 2009 |
2 other studies available for sotalol and Ventricular Dysfunction
Article | Year |
---|---|
[Possibility of differentiated treatment of ventricular heart rate disturbances based on mechanism of their development].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Sotalol; Ventricular Dysfunction | 2005 |
Fatal torsade de pointes with d,l-sotalol and low potassium.
Topics: Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Electrocardiography; Fatal Outcome; Female; H | 1999 |